> Retour à la liste des séminaires


Lundi 3 Février 2020
De 9h30 à 11h
Centre de recherche - Paris - Chez Marie

séminaire PMS épigénétique (EpiProMeS)

Dr. Paola Arimondo (Institut Pasteur) works at the interface of Chemistry and Biology to design new chemical molecules targeting DNA and histone methylation. These new molecules are used to better understand the molecular processes that deregulate these modifications in cancer and constitute potential therapeutic agents to reprogram gene regulation in cancer cells.

Dr Yuna Blum (CIT Program, French League Against Cancer) is an expert in (epi)genetic data analyses. Her presentation will focus on the heterogeneity of DNA methylation and histone marks, both among pancreatic cancer patients and within one tumor using signal deconvolution tools.


Leanne De Koning
Manager PMS épigénétique/mélanome uvéal

Institut Curie

Invité(e)(s) par

Dr Geneviève Almouzni
Domain 2 - UMR 3664 - Nuclear Dynamics

Institut Curie